58e1c8014a475c443309fd5f2ce672aa_file-5c7d91cb2bb8c2e5f51c0e3c3682d676cf46828c.ipynb

epilepsy-comorbidity-analysis.ipynb

Epilepsy Comorbidity Analysis using SCAIView
This notebook contains the Quantification of gene overlap comparing Epilepsy with other disorders using text mining
Authors: Daniel Domingo-Fernández and Charles Tapley Hoyt
Following, the set of queries used in this analysis
Reference queries:

[MeSH Disease:"Epilepsy"]
[MeSH Disease:"Alzheimer Disease"]
[MeSH Disease:"Tuberculosis"]
[MeSH Disease:"Parkinson Disease"]
[MeSH Disease:"Dementia"]
[MeSH Disease:"Migraine Disorders"]
[MeSH Disease:"Diabetes Mellitus"]
[MeSH Disease:"Colonic Neoplasms"]
[MeSH Disease:"Pulmonary Disease Chronic Obstructive"]
[MeSH Disease:"Peptic Ulcer"]
[MeSH Disease:"Anxiety Disorders"]
[MeSH Disease:"Urinary Incontinence"]
[MeSH Disease:"Cataract"]
[MeSH Disease:"Hypertension"]
[MeSH Disease:"Arthritis"]

Queries used for calculating pleitropy rates

[MeSH Disease:"Epilepsy"] AND [MeSH Disease:"Alzheimer Disease"]
[MeSH Disease:"Epilepsy"] AND [MeSH Disease:"Parkinson Disease"]
[MeSH Disease:"Epilepsy"] AND [MeSH Disease:"Dementia"]
[MeSH Disease:"Epilepsy"] AND [MeSH Disease:"Migraine Disorders"]
[MeSH Disease:"Epilepsy"] AND [MeSH Disease:"Diabetes Mellitus"]
[MeSH Disease:"Epilepsy"] AND [MeSH Disease:"Colonic Neoplasms"]
[MeSH Disease:"Epilepsy"] AND [MeSH Disease:"Pulmonary Disease Chronic Obstructive"]
[MeSH Disease:"Epilepsy"] AND [MeSH Disease:"Anxiety Disorders"]
[MeSH Disease:"Epilepsy"] AND [MeSH Disease:"Urinary Incontinence"]
[MeSH Disease:"Epilepsy"] AND [MeSH Disease:"Cataract"]
[MeSH Disease:"Epilepsy"] AND [MeSH Disease:"Hypertension"]
[MeSH Disease:"Epilepsy"] AND [MeSH Disease:"Arthritis"]

The queries were retrieved using SCAIView version 1.7.3
Corresponding to the indexing of MEDLINE on 2016-07-14T13:50:07.797575Z.
*Note that the reference queries might take time since thousand of articles need to be analyzed.

Kyso beta

epilepsy-comorbidity-analysis

Newsletter

Get the best new Kyso studies in your inbox every week.

Comments